GSA Capital Partners LLP Acquires 36,827 Shares of Trupanion, Inc. (NASDAQ:TRUP)

Key Points

• GSA Capital Partners LLP increased its stake in Trupanion, Inc. by 283.9% during Q1, now holding approximately 49,798 shares valued at $1.86 million.
• Trupanion reported earnings of ($0.03) per share for the quarter, surpassing estimates, with revenues up 11.7% year-over-year, totaling $341.98 million.
• Insider selling occurred with COO John R. Gallagher and CEO Margaret Tooth selling 4,000 shares each, resulting in a decrease of 12.92% and 3.26% in their positions, respectively.

GSA Capital Partners LLP boosted its holdings in Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 283.9% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 49,798 shares of the financial services provider's stock after purchasing an additional 36,827 shares during the quarter. GSA Capital Partners LLP owned about 0.12% of Trupanion worth $1,856,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of TRUP. Raymond James Financial Inc. bought a new stake in Trupanion during the fourth quarter worth $593,000. Commonwealth Equity Services LLC increased its position in shares of Trupanion by 13.4% during the fourth quarter. Commonwealth Equity Services LLC now owns 16,345 shares of the financial services provider's stock valued at $788,000 after acquiring an additional 1,928 shares during the last quarter. American Century Companies Inc. bought a new position in Trupanion in the 4th quarter valued at $1,111,000. Sei Investments Co. grew its stake in Trupanion by 36.1% in the 4th quarter. Sei Investments Co. now owns 6,818 shares of the financial services provider's stock valued at $329,000 after purchasing an additional 1,810 shares during the period. Finally, KLP Kapitalforvaltning AS bought a new position in Trupanion in the 4th quarter valued at $304,000.

Insider Buying and Selling

In related news, CFO Fawwad Qureshi sold 2,534 shares of the stock in a transaction dated Thursday, May 29th. The stock was sold at an average price of $48.31, for a total transaction of $122,417.54. Following the sale, the chief financial officer owned 3,545 shares of the company's stock, valued at approximately $171,258.95. This represents a 41.68% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Margaret Tooth sold 4,000 shares of the stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $45.86, for a total value of $183,440.00. Following the sale, the chief executive officer directly owned 118,784 shares in the company, valued at $5,447,434.24. This trade represents a 3.26% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 11,562 shares of company stock valued at $544,870. Company insiders own 5.42% of the company's stock.

Trupanion Stock Performance

Trupanion stock traded down $1.22 during trading on Friday, hitting $46.19. The stock had a trading volume of 363,745 shares, compared to its average volume of 598,713. Trupanion, Inc. has a 1 year low of $29.70 and a 1 year high of $57.90. The company has a quick ratio of 1.70, a current ratio of 1.70 and a debt-to-equity ratio of 0.38. The stock's 50 day moving average is $50.96 and its two-hundred day moving average is $43.99. The stock has a market cap of $1.98 billion, a price-to-earnings ratio of -461.82 and a beta of 1.82.

Trupanion (NASDAQ:TRUP - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The financial services provider reported ($0.03) EPS for the quarter, topping the consensus estimate of ($0.05) by $0.02. The company had revenue of $341.98 million during the quarter, compared to the consensus estimate of $337.81 million. Trupanion had a negative net margin of 0.32% and a negative return on equity of 1.33%. Trupanion's revenue for the quarter was up 11.7% on a year-over-year basis. During the same period last year, the firm earned ($0.16) EPS. As a group, analysts predict that Trupanion, Inc. will post 0.13 EPS for the current year.

Analysts Set New Price Targets

A number of brokerages have issued reports on TRUP. Lake Street Capital reduced their price objective on Trupanion from $65.00 to $60.00 and set a "buy" rating for the company in a research note on Friday, May 2nd. Piper Sandler upped their price objective on Trupanion from $52.00 to $62.00 and gave the company an "overweight" rating in a research note on Thursday, July 3rd. Two research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $53.80.

Trupanion Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.